-
1
-
-
67349228410
-
The beta cell lesion in type 2 diabetes: There has to be a primary functional abnormality
-
Kahn SE, Zraika S, Utzschneider KM, Hull RL. The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia 2009;52:1003-1012
-
(2009)
Diabetologia
, vol.52
, pp. 1003-1012
-
-
Kahn, S.E.1
Zraika, S.2
Utzschneider, K.M.3
Hull, R.L.4
-
2
-
-
77954323314
-
The stunned beta cell: A brief history
-
Ferrannini E. The stunned beta cell: a brief history. Cell Metab 2010;11:349-352
-
(2010)
Cell Metab
, vol.11
, pp. 349-352
-
-
Ferrannini, E.1
-
4
-
-
34250307235
-
A K ATP channel-dependent pathway within alpha cells regulates glucagon release from both rodent and human islets of Langerhans
-
MacDonald PE, De Marinis YZ, Ramracheya R, et al. A K ATP channel-dependent pathway within alpha cells regulates glucagon release from both rodent and human islets of Langerhans. PLoS Biol 2007;5:e143
-
(2007)
PLoS Biol
, vol.5
-
-
MacDonald, P.E.1
De Marinis, Y.Z.2
Ramracheya, R.3
-
5
-
-
33846856711
-
α-cells of the endocrine pancreas: 35 years of research but the enigma remains
-
DOI 10.1210/er.2006-0007
-
Gromada J, Franklin I, Wollheim CB. α-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev 2007;28:84-116 (Pubitemid 46220851)
-
(2007)
Endocrine Reviews
, vol.28
, Issue.1
, pp. 84-116
-
-
Gromada, J.1
Franklin, I.2
Wollheim, C.B.3
-
6
-
-
0021711003
-
Insulin within islets is a physiologic glucagon release inhibitor
-
Maruyama H, Hisatomi A, Orci L, Grodsky GM, Unger RH. Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest 1984;74:2296-2299 (Pubitemid 15197376)
-
(1984)
Journal of Clinical Investigation
, vol.74
, Issue.6
, pp. 2296-2299
-
-
Maruyama, H.1
Hisatomi, A.2
Orci, L.3
-
7
-
-
0023820363
-
The order of islet microsvascular cellular perfusion is B - A - D in the perfused rat pancreas
-
Samols E, Stagner JI, Ewart RBL, Marks V. The order of islet microvascular cellular perfusion is B - A - D in the perfused rat pancreas. J Clin Invest 1988;82:350-353 (Pubitemid 18262537)
-
(1988)
Journal of Clinical Investigation
, vol.82
, Issue.1
, pp. 350-353
-
-
Samols, E.1
Stagner, J.I.2
Ewart, R.B.L.3
Marks, V.4
-
8
-
-
0034801880
-
Immunoneutralization of somatostatin, insulin, and glucagon causes alterations in islet cell secretion in the isolated perfused human pancreas
-
DOI 10.1097/00006676-200110000-00012
-
Brunicardi FC, Kleinman R, Moldovan S, et al. Immunoneutralization of somatostatin, insulin, and glucagon causes alterations in islet cell secretion in the isolated perfused human pancreas. Pancreas 2001;23:302-308 (Pubitemid 32910980)
-
(2001)
Pancreas
, vol.23
, Issue.3
, pp. 302-308
-
-
Brunicardi, F.C.1
Kleinman, R.2
Moldovan, S.3
Nguyen, T.-H.L.4
Watt, P.C.5
Walsh, J.6
Gingerich, R.7
-
9
-
-
2542532408
-
Regulation of α-cell function by the β-cell during hypoglycemia in Wistar rats: The "switch-off" hypothesis
-
Zhou H, Tran PO, Yang S, et al. Regulation of α-cell function by the β-cell during hypoglycemia in Wistar rats: the "switch-off" hypothesis. Diabetes 2004;53:1482-1487
-
(2004)
Diabetes
, vol.53
, pp. 1482-1487
-
-
Zhou, H.1
Tran, P.O.2
Yang, S.3
-
10
-
-
63249127193
-
Somatostatin secreted by islet δ-cells fulfills multiple roles as a paracrine regulator of islet function
-
Hauge-Evans AC, King AJ, Carmignac D, et al. Somatostatin secreted by islet δ-cells fulfills multiple roles as a paracrine regulator of islet function. Diabetes 2009;58:403-411
-
(2009)
Diabetes
, vol.58
, pp. 403-411
-
-
Hauge-Evans, A.C.1
King, A.J.2
Carmignac, D.3
-
11
-
-
2642593026
-
Autonomic mediation of glucagon secretion during hypoglycemia: Implications for impaired alpha-cell responses in type 1 diabetes
-
DOI 10.2337/diabetes.47.7.995
-
Taborsky GJ Jr, Ahrén B, Havel PJ. Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired alpha-cell responses in type 1 diabetes. Diabetes 1998;47:995-1005 (Pubitemid 28294539)
-
(1998)
Diabetes
, vol.47
, Issue.7
, pp. 995-1005
-
-
Taborsky Jr., G.J.1
Ahren, B.2
Havel, P.J.3
-
12
-
-
34548207654
-
Brain glucose sensing, counter-regulation, and energy homeostasis
-
Bethesda
-
Marty N, Dallaporta M, Thorens B. Brain glucose sensing, counter-regulation, and energy homeostasis. Physiology (Bethesda) 2007;22:241-251
-
(2007)
Physiology
, vol.22
, pp. 241-251
-
-
Marty, N.1
Dallaporta, M.2
Thorens, B.3
-
13
-
-
35748957503
-
The physiology of glucagon-like peptide 1
-
DOI 10.1152/physrev.00034.2006
-
Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007;87:1409-1439 (Pubitemid 350041474)
-
(2007)
Physiological Reviews
, vol.87
, Issue.4
, pp. 1409-1439
-
-
Holst, J.J.1
-
14
-
-
33745301045
-
Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: Further evidence for the intraislet insulin hypothesis
-
DOI 10.2337/diabetes.55.04.06.db05-1449
-
Meier JJ, Kjems LL, Veldhuis JD, Lefèbvre P, Butler PC. Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis. Diabetes 2006;55:1051-1056 (Pubitemid 44100181)
-
(2006)
Diabetes
, vol.55
, Issue.4
, pp. 1051-1056
-
-
Meier, J.J.1
Kjems, L.L.2
Veldhuis, J.D.3
Lefebvre, P.4
Butler, P.C.5
-
15
-
-
56049086867
-
Insulin as a physiological modulator of glucagon secretion
-
Bansal P, Wang Q. Insulin as a physiological modulator of glucagon secretion. Am J Physiol Endocrinol Metab 2008;295:E751-E761
-
(2008)
Am J Physiol Endocrinol Metab
, vol.295
-
-
Bansal, P.1
Wang, Q.2
-
16
-
-
78049300087
-
Insulin reciprocally regulates glucagon secretion in humans
-
Cooperberg BA, Cryer PE. Insulin reciprocally regulates glucagon secretion in humans. Diabetes 2010;59:2936-2940
-
(2010)
Diabetes
, vol.59
, pp. 2936-2940
-
-
Cooperberg, B.A.1
Cryer, P.E.2
-
17
-
-
0036227054
-
Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response
-
Banarer S, McGregor VP, Cryer PE. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response. Diabetes 2002;51:958-965 (Pubitemid 34438337)
-
(2002)
Diabetes
, vol.51
, Issue.4
, pp. 958-965
-
-
Banarer, S.1
McGregor, V.P.2
Cryer, P.E.3
-
18
-
-
14644439841
-
Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: Documentation of the intraislet insulin hypothesis in humans
-
DOI 10.2337/diabetes.54.3.757
-
Raju B, Cryer PE. Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans. Diabetes 2005;54:757-764 (Pubitemid 40322079)
-
(2005)
Diabetes
, vol.54
, Issue.3
, pp. 757-764
-
-
Raju, B.1
Cryer, P.E.2
-
19
-
-
18144396132
-
Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans
-
DOI 10.2337/diacare.28.5.1124
-
Gosmanov NR, Szoke E, Israelian Z, et al. Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans. Diabetes Care 2005;28:1124-1131 (Pubitemid 40616623)
-
(2005)
Diabetes Care
, vol.28
, Issue.5
, pp. 1124-1131
-
-
Gosmanov, N.R.1
Szoke, E.2
Israelian, Z.3
Smith, T.4
Cryer, P.E.5
Gerich, J.E.6
Meyer, C.7
-
20
-
-
33644684529
-
Increasing the decrement in insulin secretion improves glucagon responses to hypoglycemia in advanced type 2 diabetes
-
DOI 10.2337/diacare.28.11.2691
-
Israelian Z, Gosmanov NR, Szoke E, et al. Increasing the decrement in insulin secretion improves glucagon responses to hypoglycemia in advanced type 2 diabetes. Diabetes Care 2005;28:2691-2696 (Pubitemid 43951161)
-
(2005)
Diabetes Care
, vol.28
, Issue.11
, pp. 2691-2696
-
-
Israelian, Z.1
Gosmanov, N.R.2
Szoke, E.3
Schorr, M.4
Bokhari, S.5
Cryer, P.E.6
Gerich, J.E.7
Meyer, C.8
-
21
-
-
72249093748
-
β-cell-mediated signaling predominates over direct α-cell signaling in the regulation of glucagon secretion in humans
-
Cooperberg BA, Cryer PE. β-cell-mediated signaling predominates over direct α-cell signaling in the regulation of glucagon secretion in humans. Diabetes Care 2009;32:2275-2280
-
(2009)
Diabetes Care
, vol.32
, pp. 2275-2280
-
-
Cooperberg, B.A.1
Cryer, P.E.2
-
22
-
-
0022189557
-
External and internal standards in the single-isotope derivative (radioenzymatic) measurement of plasma norepinephrine and epinephrine
-
Shah SD, Clutter WE, Cryer PE. External and internal standards in the single-isotope derivative (radioenzymatic) measurement of plasma norepinephrine and epinephrine. J Lab Clin Med 1985;106:624-629 (Pubitemid 16032502)
-
(1985)
Journal of Laboratory and Clinical Medicine
, vol.106
, Issue.6
, pp. 624-629
-
-
Shah, S.D.1
Clutter, W.E.2
Cryer, P.E.3
-
23
-
-
0014951784
-
Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion
-
Müller WA, Faloona GR, Aguilar-Parada E, Unger RH. Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. N Engl J Med 1970;283:109-115
-
(1970)
N Engl J Med
, vol.283
, pp. 109-115
-
-
Müller, W.A.1
Faloona, G.R.2
Aguilar-Parada, E.3
Unger, R.H.4
-
24
-
-
0023109225
-
Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus
-
Reaven GM, Chen YD, Golay A, Swislocki AL, Jaspan JB. Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1987;64:106-110 (Pubitemid 17015886)
-
(1987)
Journal of Clinical Endocrinology and Metabolism
, vol.64
, Issue.1
, pp. 106-110
-
-
Reaven, G.M.1
Chen, Y.-D.I.2
Golay, A.3
-
26
-
-
34250854205
-
The role of α-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications
-
DOI 10.1210/er.2006-0026
-
Dunning BE, Gerich JE. The role of α-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications. Endocr Rev 2007;28:253-283 (Pubitemid 46984828)
-
(2007)
Endocrine Reviews
, vol.28
, Issue.3
, pp. 253-283
-
-
Dunning, B.E.1
Gerich, J.E.2
-
27
-
-
34249858600
-
Fasting hyperglycemia impairs glucose- But not insulin-mediated suppression of glucagon secretion
-
DOI 10.1210/jc.2006-1515
-
Abdul-Ghani M, DeFronzo RA. Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion. J Clin Endocrinol Metab 2007;92:1778-1784 (Pubitemid 46997188)
-
(2007)
Journal of Clinical Endocrinology and Metabolism
, vol.92
, Issue.5
, pp. 1778-1784
-
-
Abdul-Ghani, M.1
DeFronzo, R.A.2
|